A Study to Validate the Safety and Feasibility of ArtiSential in Colorectal Cancer Surgery Using Prospectively Constructed Multi-center Registry
Recruiting
- Conditions
- Rectal CancerRectosigmoid CancerRectosigmoid Junction Cancer
- Interventions
- Device: ArtiSential
- Registration Number
- NCT05566249
- Lead Sponsor
- Samsung Medical Center
- Brief Summary
This study is to validate the safety and feasibility of ArtiSential (Articulating laparoscopic instrument) colorectal surgery and compare it with robotic surgery for patients with rectal cancer and rectosigmoid junction cancer.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 1000
Inclusion Criteria
- Age : 18 ~ 80 year old male or female
- Biopsy-proven adenocarcinoma
- Rectal cancer or Rectosigmoid junction cancer
- Primary cancer
- Non-metastatic cancer
- Planned (or elective) curative resection
- Low anterior resection with double-stapled technique
Exclusion Criteria
- Preoperative systemic chemotherapy
- Distant metastasis at initial diagnosis
- Palliative surgery
- Emergent surgery
- Lynch syndrome or FAP-associated cancer
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description ArtiSential group ArtiSential Patients undergoing laparoscopic surgery using ArtiSential
- Primary Outcome Measures
Name Time Method Surgical failure 1 month conversion, postoperative complications, or less than 12 harvested lymph nodes
Cost 1 month Total medical cost during hospital stay for surgery
- Secondary Outcome Measures
Name Time Method Oncologic outcomes 5-year 5-year Overall Survival
Trial Locations
- Locations (1)
Samsung Medical Center
🇰🇷Seoul, Korea, Republic of